The Impact of the Plasma BNP Levels for the Prediction of Re-hospitalization in the Management of Patients with Heart Failure
Hideaki Suwa(National Cerebral and Cardiovascular Center), Masafumi Kitakaze(Hanwa Memorial Hospital), Toshihisa Anzai(Hokkaido University), Takashi Washio(The University of Osaka), Akira Hunada(National Cerebral and Cardiovascular Center), Takuya Hasegawa(National Cerebral and Cardiovascular Center), Takahiro Ohara(Tohoku Medical and Pharmaceutical University), Yasuo Sugano(keiyu Hospital), Atsushi Nakano(National Cerebral and Cardiovascular Center), Hideaki Kanzaki(National Cerebral and Cardiovascular Center)
Cited by 0
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
|Nature Medicine|2002|722
Prevalence, Clinical Features, and Prognosis of Acute Myocardial Infarction Attributable to Coronary Artery Embolism
|Circulation|2015|401
Regulatory Role of Dendritic Cells in Postinfarction Healing and Left Ventricular Remodeling
|Circulation|2012|304
Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling
|Journal of the American College of Cardiology|2002|302